Please login to the form below

Not currently logged in
Email:
Password:

Ironwood Pharmaceuticals

This page shows the latest Ironwood Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

bluebird bio gears up for split

bluebird bio gears up for split

Consylman has more than 25 years of experience, mostly recently as CFO at Ironwood Pharmaceuticals and, before that, at Analogic Corporation and Biogen.

Latest news

More from news
Approximately 2 fully matching, plus 7 partially matching documents found.

Latest Intelligence

  • Deal Watch June 2016 Deal Watch June 2016

    In a "mirror deal" in April this year, AstraZenenca licensed US rights to Zurampic and the fixed dose combination to Ironwood Pharmaceuticals for $100m upfront and up to $165m in further ... collaboration, licence, equity. 73.5. PAION/ Cosmo

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Belgium's TiGenix appoints Dr Gregory Gordon Belgium's TiGenix appoints Dr Gregory Gordon

    Dr Gordon joins TiGenix from Nestlé Health Science, where he was global clinical affairs lead, gastrointestinal health and prior to that he has worked at Stealth BioTherapeutics, Ironwood Pharmaceuticals and Parexel. ... Meanwhile, Valles-Sukkar arrives

  • Vertex poaches new finance chief from Ironwood Pharmaceuticals Vertex poaches new finance chief from Ironwood Pharmaceuticals

    Boston-based biotech company appoints Tom Graney. Vertex lured Tom Graney away from Ironwood Pharmaceuticals, appointing him as its new senior vice president and chief financial officer. ... Graney most recently spent three years at Ironwood

  • Ironwood Pharmaceuticals appoints chief development officer Ironwood Pharmaceuticals appoints chief development officer

    Dr Christopher Wright joins from Axcella Health. Ironwood Pharmaceuticals has appointed Dr Christopher Wright as its new senior vice president of global development and chief development officer in a role that ... Mark Currie, chief scientific officer

  • Proteostasis Therapeutics strengthens leadership team Proteostasis Therapeutics strengthens leadership team

    James DeTore (pictured) becomes the biopharmaceutical firm's chief financial officer, bringing experience from bluebird bio, Ironwood Pharmaceuticals and Microbia. ... Center. Chhabra said: “Geoffrey's extensive experience leading clinical development

  • Ironwood appoints Edward Owens to board Ironwood appoints Edward Owens to board

    Ironwood Pharmaceuticals has appointed Edwards Owens to the company's board of directors. ... Peter Hecht, CEO of Ironwood, commented on the appointment of Owens: “He has deeply probed the strategy, growth, successes and challenges of nearly every

More from appointments
Approximately 2 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....